Latest AI (Artificial Intelligence) News
AI Set to Transform Clinical Trials in 2026
In 2026, AI-powered simulations and real-world data will reshape clinical trial design, reducing timelines by at least six months through predictive modeling and protocol refinement. Firms face pressure to show ROI after heavy investments, with agentic AI enabling proactive strategies amid regulatory challenges.
This positions forward-thinking organizations to turn data complexity into assets for faster drug development.
MIT Predicts AI Companions as Top 2026 Breakthrough
MIT lists AI companions as the #1 breakthrough for 2026, driven by advances in LLMs improving conversational fluency and emotional simulation. These systems enable more human-like interactions, transforming personal and social AI applications.
Other predictions include mechanistic interpretability for AI safety and hyperscale data centers.
Enterprises to Adopt AI Agents in 2026
2026 will see widespread enterprise adoption of AI agents, which execute multi-step workflows autonomously unlike passive chatbots. Private capital firms are deploying AI in due diligence and deal execution, automating end-to-end processes.
Agents enable continuous market mapping and team coordination for complex tasks.
Canadian Alliance Launches LIGAND-AI for Drug Discovery
A Canadian-led consortium secured $26M for LIGAND-AI, using AI and open science to generate datasets for protein-ligand interactions across thousands of human proteins. Led by UHN, SGC, and SickKids with Pfizer, it advances Target 2035 for precision therapies.
The project emphasizes open-access tools to accelerate global drug development.
IMF Credits AI Investment for Upgraded 2026 Global Growth
IMF raised its 2026 global growth forecast to 3.3%, attributing gains to AI-driven investments easing trade drags. However, it warns of risks from concentrated benefits among few players.
AI is quietly propping up the economy through infrastructure and capital inflows.
AI Dominates Davos 2026 Discussions
AI infiltrated every Davos conversation, with leaders like Microsoft's Nadella stressing infrastructure needs for even deployment. Anthropic's CEO warned of AGI risks and white-collar job losses, urging regulation.
Focus shifted to implementation, societal impacts, and geopolitical competition.
MIT Forecasts Base-Edited Babies and Embryo Scoring for 2026
MIT predicts base-edited babies and embryo scoring as 2026 breakthroughs, using matured polygenic risk scores from cheap genome sequencing. These estimate disease risks and traits like cognitive ability for IVF selection.
Advances enable predictive indicators beyond single-gene screening.
AI Model Diagnoses Heart Disease from 10-Second EKG
University of Michigan's AI diagnoses coronary microvascular dysfunction using standard EKGs, replacing invasive tests with seconds-long analysis. Tested clinically, it aids hospitals lacking advanced equipment for this hard-to-detect condition.
Published December 16, 2025, in Scientific Reports.
AI-Designed Molecule Boosts Pancreatic Cancer Treatment
AI-generated molecule overcomes tumor resistance, enhancing chemotherapy effectiveness against pancreatic cancer. It targets mechanisms humans might miss, potentially improving survival rates.
Breakthrough announced December 16, 2025.
Fujitsu's AI Links Gut Health to Brain Function
Fujitsu and Kirin developed AI QSP model simulating food impacts on cognition via gut-brain axis, like citicoline. It speeds functional food discovery, cutting trial costs.
Dated December 2, 2025.
AI EEG Systems Detect Dementia with 97% Accuracy
Ă–rebro University's AI analyzes brain waves to distinguish dementia types, achieving over 97% accuracy via federated learning for privacy. Combines networks for 80%+ classification of Alzheimer's and frontotemporal dementia.
Announced November 27, 2025.
UK's ARIA Advances AI Scientists for Automated Research
ARIA develops AI Scientists to hypothesize, experiment in automated labs, and iterate findings independently. This could scale breakthroughs by exploring more directions continuously.
Focuses on societal impacts through non-obvious pattern spotting.